Allan C. Halpern

Allan C. Halpern, MD, is a board-certified dermatologist and internist at Memorial Sloan Kettering Cancer Center (MSK), serving as Chief of the Dermatology Service and Co-Leader of the Melanoma Disease Management Team. His clinical focus involves early detection and management of melanoma in high-risk patients.

• Education: MD from Albert Einstein College of Medicine
• Residencies: Hospital of the University of Pennsylvania and Montefiore Medical Center

Dr. Halpern specializes in:

• Prevention and early detection of melanoma in patients with dysplastic nevi
• Non-invasive diagnosis of skin cancer using optical imaging techniques
• Epidemiological studies of melanoma risk factors
• Genetic and environmental influences on mole development in children

Scientific Awards:

• Multiple Castle Connolly America’s Top Doctor awards (2005-2025)
• Recognized as a top physician in New York Magazine (2005-2020)

At MSK, Dr. Halpern leads a computerized digital imaging system for mole monitoring and collaborates with multidisciplinary teams in melanoma treatment. His research explores automated image analysis and subsurface microscopy for skin cancer diagnosis.